glp-1 type 2 diabetes Clinical Focus on Agonists in Mellitus GLP-1 Receptor Agonists as Treatments

Especially in South Asians, who tend to develop risk factors for T2DM and MI at younger ages and lower BMI, they found an association of a DPP4 SNP with ApoB level (44)

This article examines the relationship between GLP-1 medications and stool colour, providing evidence-based guidance on managing digestive symptoms and recognising warning signs requiring clinical assessment

Wegovy is FDA-approved for chronic weight management in adults and pediatric patients aged 12 years and older with obesity (BMI 30 kg/m for adults, 95th percentile for age and sex in pediatrics) or overweight (BMI 27 kg/m for adults, 85th percentile for pediatrics) with at least one weight-related comorbidity

The 150-minute weekly minimum Beyond post-meal walks, aim for at least 150 minutes of moderate-intensity aerobic activity per week

While metformin primarily controls fasting blood sugar, acarbose regulates postprandial glucose levels